Company news

Hunan Warrant Pharmaceutical Co., Ltd. news in 2025

Hunan Warrant Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on Resolutions of the 7th Extraordinary Meeting of the 4th Board of Directors

December 26, 2025

Announcement on Election of Employee Representative Directors for the 4th Board of Directors

December 24, 2025

Announcement on Changing Registered Capital, Canceling Board of Supervisors, Adjusting the Number Directors of the Board of Directors, Amending the "Articles of Association", Handling Industrial and Commercial Change Registration, and Formulating and Revising Some Governance Systems

December 10, 2025

Announcement on Resolutions of the 3rd Meeting of the 4th Board of Directors

October 30, 2025

Announcement on Voluntary Disclosure of Prospective Winning in the National Centralized Drug Procurement

October 28, 2025

Announcement on Progress in Co-investment with Related Parties in Capital Increase to Joint-stock Company and Related Party Transactions

September 24, 2025

Announcement on Shareholding Reduction Result of Shareholders, Directors and Their Persons Acting in Concert with Over 5% Shares

September 12, 2025

Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance Briefing

September 11, 2025

Announcement on Progress in Capital Increase of Holding Subsidiary to Introduce Strategic Investors and Related Party Transactions

September 7, 2025

Indicative Announcement on Changes in Equity Interests Reaching a Multiple of 5% by Shareholders and Directors Holding 5% or More of Shares and Their Persons Acting in Concert

September 3, 2025

Special Report on Semi-annual Deposit, Management and Actual Use of Raised Funds in 2025

August 29, 2025

Announcement on Shareholding Reduction Plan by Shareholders, Directors and Their Persons Acting in Concert with Over 5% Shares

July 27, 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

June 27, 2025

Announcement on Voluntary Disclosure of Drugs Passing Consistency Evaluation of Quality and Efficacy of Generic Drugs

June 26, 2025

Announcement on Correction of Announcement on Adjustment and Extension of Some Sub-projects of Investment Projects Financed by Raised Funds

June 13, 2025

Notice on Convening the 1st Extraordinary General Meeting of 2025

June 11, 2025

Announcement on Abnormal Fluctuations in Stock Trading

May 30, 2025

Announcement on Litigation Progress

May 26, 2025

Announcement on Implementation of Dividend Distribution for 2024

May 22, 2025

Announcement on Diluted Immediate Return, Mitigating Measures, and Related Entity Commitments for Issuance of A-shares to Specific Objects in 2024 (Revised Draft)

May 12, 2025